Scott C Virgil

USPTO Granted Patents = 14 (Patent Applications = 6)

EPO Patents = 5 (Patent Applications = 9)

Average Co-Inventor Count = 7.3

ph-index = 5

Forward Citations = 49(Granted Patents)

Company Filing History:

14 out of 4,550

California Institute of Technology

patents

2 out of 15,475

University of California

where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12486280 - CDK inhibitors and uses thereof (2025-12-02),

2. 11390585 - Quaternary heteroatom containing compounds (2022-07-19),

3. 10906875 - Quaternary heteroatom containing compounds (2021-02-02),

4. 10781213 - Methods for preparing bis-tetrahydroisoquinoline-containing compounds (2020-09-22),

5. 10745354 - Methods for enantioselective allylic alkylation of esters, lactones, and lactams with unactivated allylic alcohols (2020-08-18),

6. 10526334 - Methods for preparing bis-tetrahydroisoquinoline-containing compounds (2020-01-07),

7. 10358422 - Methods for enantioselective allylic alkylation of esters, lactones, and lactams with unactivated allylic alcohols (2019-07-23),

8. 10343996 - Quaternary heteroatom containing compounds (2019-07-09),

9. 10035769 - Quaternary heteroatom containing compounds (2018-07-31),

10. 9422259 - Synthetic transtaganolide and basiliolide products, derivatives thereof, and synthesis methods thereof (2016-08-23),

11. 9249170 - Cyclic alkyl amino carbene (CAAC) ruthenium complexes as improved catalysts for ethenolysis reactions (2016-02-02),

12. 8912347 - Synthetic transtaganolide and basiliolide products, derivatives thereof, and synthesis methods thereof (2014-12-16),

13. 8822679 - Quaternary heteroatom containing compounds (2014-09-02),

14. 8653307 - Liphagal enantiomers and their derivatives and precursors, and enantioselective methods of making the same (2014-02-18),

Title: Scott C. Virgil: Innovator in Heterocyclic Compounds

Introduction

Scott C. Virgil is a notable inventor based in Pasadena, California, who has made significant contributions to the field of chemical innovations. With a robust portfolio of 13 patents, Virgil's work primarily focuses on the development of heterocyclic compounds containing quaternary centers, highlighting his expertise and creativity in chemical research.

Latest Patents

Among his latest patents, Virgil introduces advancements in quaternary heteroatom-containing compounds. His innovations provide methods for preparing novel heterocyclic compounds with specific structural features. Notably, his patented method involves treating a compound of formula (I) with a transition metal catalyst, conducted under alkylation conditions that consider valence and stability, ultimately leading to the production of compounds as outlined in formula (II).

Career Highlights

Virgil's impressive career includes affiliations with prestigious institutions such as the California Institute of Technology and the University of California. His experiences at these renowned organizations have fostered an environment where his inventive spirit could flourish, enabling him to focus on groundbreaking research and development.

Collaborations

Throughout his journey, Scott C. Virgil has had the opportunity to collaborate with esteemed colleagues, including Brian M. Stoltz and David E. White. These partnerships have enriched his research endeavors and led to innovative breakthroughs in the field of heterocyclic compounds.

Conclusion

Overall, Scott C. Virgil stands out as a prominent inventor whose work in developing quaternary heteroatom-containing compounds continues to push the boundaries of chemical science. With a strong foundation in both academic and collaborative settings, his contributions will undoubtedly have a lasting impact on the industry.

This text is generated by artificial intelligence and may not be accurate.